客户评鉴
深圳欣博盛生物科技有限公司（欣博盛生物科技）是 一家致力于生命科学和生物技术领域的高科技企业。公司由在国内科研试剂领域有着十几年从业经验的专业技术团队和企业管理团队组建而成，公司自主研发的ELISA试剂盒，品质卓越，行业领先；在国内众多重点实验室广泛使用，深受广大科研人员的好评。欣博盛品牌 ELISA试剂盒自推出以来已先后在Nature，PNAS, Cell research等国际权威杂志文章中被引用，欣博盛生物共有2500篇文献。
文献筛选
种属：
种属：
样本类型：
| 文章 | 指标 | 种属 | 样本类型 |
|---|---|---|---|
| Annema, W., et al. (2022). Elevated levels of apolipoprotein D predict poor outcome in patients with suspected or established coronary artery disease. Atherosclerosis. | IL-6IL-βTNF-α | Human | 示例文本 |
| Annema, W., et al. (2022). Elevated levels of apolipoprotein D predict poor outcome in patients with suspected or established coronary artery disease. Atherosclerosis. | IL-6IL-βTNF-α | Human | 示例文本 |
| Annema, W., et al. (2022). Elevated levels of apolipoprotein D predict poor outcome in patients with suspected or established coronary artery disease. Atherosclerosis. | IL-6IL-βTNF-α | Human | 示例文本 |
| Annema, W., et al. (2022). Elevated levels of apolipoprotein D predict poor outcome in patients with suspected or established coronary artery disease. Atherosclerosis. | IL-6IL-βTNF-α | Human | 示例文本 |
| Annema, W., et al. (2022). Elevated levels of apolipoprotein D predict poor outcome in patients with suspected or established coronary artery disease. Atherosclerosis. | IL-6IL-βTNF-α | Human | 示例文本 |
| Annema, W., et al. (2022). Elevated levels of apolipoprotein D predict poor outcome in patients with suspected or established coronary artery disease. Atherosclerosis. | IL-6IL-βTNF-α | Human | 示例文本 |
| Annema, W., et al. (2022). Elevated levels of apolipoprotein D predict poor outcome in patients with suspected or established coronary artery disease. Atherosclerosis. | IL-6IL-βTNF-α | Human | 示例文本 |
| Annema, W., et al. (2022). Elevated levels of apolipoprotein D predict poor outcome in patients with suspected or established coronary artery disease. Atherosclerosis. | IL-6IL-βTNF-α | Human | 示例文本 |
| Annema, W., et al. (2022). Elevated levels of apolipoprotein D predict poor outcome in patients with suspected or established coronary artery disease. Atherosclerosis. | IL-6IL-βTNF-α | Human | 示例文本 |
| Annema, W., et al. (2022). Elevated levels of apolipoprotein D predict poor outcome in patients with suspected or established coronary artery disease. Atherosclerosis. | IL-6IL-βTNF-α | Human | 示例文本 |
| Annema, W., et al. (2022). Elevated levels of apolipoprotein D predict poor outcome in patients with suspected or established coronary artery disease. Atherosclerosis. | IL-6IL-βTNF-α | Human | 示例文本 |
| Annema, W., et al. (2022). Elevated levels of apolipoprotein D predict poor outcome in patients with suspected or established coronary artery disease. Atherosclerosis. | IL-6IL-βTNF-α | Human | 示例文本 |
| Annema, W., et al. (2022). Elevated levels of apolipoprotein D predict poor outcome in patients with suspected or established coronary artery disease. Atherosclerosis. | IL-6IL-βTNF-α | Human | 示例文本 |
| Annema, W., et al. (2022). Elevated levels of apolipoprotein D predict poor outcome in patients with suspected or established coronary artery disease. Atherosclerosis. | IL-6IL-βTNF-α | Human | 示例文本 |
| Annema, W., et al. (2022). Elevated levels of apolipoprotein D predict poor outcome in patients with suspected or established coronary artery disease. Atherosclerosis. | IL-6IL-βTNF-α | Human | 示例文本 |
| Annema, W., et al. (2022). Elevated levels of apolipoprotein D predict poor outcome in patients with suspected or established coronary artery disease. Atherosclerosis. | IL-6IL-βTNF-α | Human | 示例文本 |
